购物车
- 全部删除
- 您的购物车当前为空
Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease.
Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,145 | 35日内发货 | |
5 mg | ¥ 7,450 | 35日内发货 | |
10 mg | ¥ 14,870 | 35日内发货 |
产品描述 | Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease. |
靶点活性 | AKR1B10 (V301L):1.8 μM, AKR1B10:33 μM, Aldose reductase:26 nM |
体内活性 | Fidarestat (1 or 4 mg/kg. p.o., daily for 4 weeks) decreases the concentrations of sorbitol and fructose in diabetic rats [2]. |
别名 | SNK 860 |
分子量 | 279.22 |
分子式 | C12H10FN3O4 |
CAS No. | 136087-85-9 |
密度 | 1.61 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 250 mg/mL (895.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容